Additional subgroup analyses of MGMT promoter methylation status and RT regimen (NF-RT vs HF-RT) did not reveal significant differences after exclusion of IDH-mutant cases (Supplement Fig. S2, S3). The gene discussed is IDH2; the disease is hydrops fetalis.